Moderna MRNA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Moderna's short-term investments?
- Moderna (MRNA) reported short-term investments of $3.3B in Q1 2026.
- How has Moderna's short-term investments changed year-over-year?
- Moderna's short-term investments decreased by 24.2% year-over-year, from $4.35B to $3.3B.
- What is the long-term trend for Moderna's short-term investments?
- Over 5 years (2020 to 2025), Moderna's short-term investments has grown at a 10.1% compound annual growth rate (CAGR), from $1.98B to $3.2B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.